Protective effect of angiotensin II receptor blocker against oxidative stress and inflammation in an oral mucositis experimental model
Open Access
- 20 August 2018
- journal article
- research article
- Published by Wiley in Journal of Oral Pathology & Medicine
- Vol. 47 (10) , 972-984
Abstract
Background: The aim of this study was to evaluate the effect of olmesartan medoxomil (Olme), an angiotensin II receptor antagonist, on oral mucositis (OM) experimental model.Methods: Oral mucositis was induced in hamsters with 5‐fluorouracil (5‐FU; 60 mg/kg day 1 and 40 mg/kg day 2). Animals (n = 10/group) were pretreated with oral Olme (1, 5, or 10 mg/kg) or vehicle 30 minutes before 5‐FU injection and daily, until day 10. Cheek pouch samples were subjected to histopathological and immunostaining analysis of IL‐1β, TNF‐α, IL‐10, TGF‐β, macrophage migration inhibitory factor (MIF), SOD, MMP‐2 and FGF‐2. In addition, IL‐1β and TNF‐α levels were evaluated by ELISA. Myeloperoxidase activity (MPO), glutathione (GSH) and malondialdehyde (MDA) levels were investigated by spectroscopic UV/VIS analysis. Reverse transcriptase polymerase chain reactions (RT‐PCRs) were used to quantify the expression of IL‐1β, TNF‐α, NF‐κBp65, MKP1 and ACE2. Inducible nitric oxide synthase (iNOS) and extracellular regulated kinase (ERK)1/2 protein levels were analysed by Western blot.Results: Treatment with 10 mg/kg Olme reduced ulceration, inflammatory cell infiltration, MPO activity, MDA levels, iNOS and ERK1/2 proteins levels, MIF expression and TNF‐α and IL‐1β of levels and gene expression. These findings were associated with a significant increase in the immunostaining of IL‐10, FGF‐2 and TGF‐β. In addition, gene expression of IL‐1β, TNF‐α, NF‐κBp65 MKP1 and ACE2 was decreased.Conclusion: Olmesartan at a dose of 10 mg/kg prevented the mucosal damage and inflammation associated with 5‐FU‐induced OM, increasing granulation and tissue repair.Keywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Universidade Federal do Rio Grande do Norte
This publication has 26 references indexed in Scilit:
- Olmesartan decreases IL-1β and TNF-α levels; downregulates MMP-2, MMP-9, COX-2, and RANKL; and upregulates OPG in experimental periodontitisNaunyn-Schmiedeberg's Archives of Pharmacology, 2013
- Angiotensin converting enzyme 2 gene expression increased compensatory for left ventricular remodeling in patients with end-stage heart failureInternational Journal of Cardiology, 2010
- ACE2 Overexpression Ameliorates Left Ventricular Remodeling and Dysfunction in a Rat Model of Myocardial InfarctionHuman Gene Therapy, 2010
- Angiotensin II revisited: new roles in inflammation, immunology and agingEMBO Molecular Medicine, 2010
- Telmisartan inhibits cytokine-induced nuclear factor-κB activation independently of the peroxisome proliferator-activated receptor-γHypertension Research, 2009
- Transgenic Angiotensin-Converting Enzyme 2 Overexpression in Vessels of SHRSP Rats Reduces Blood Pressure and Improves Endothelial FunctionHypertension, 2008
- Role of the renin–angiotensin system in vascular inflammationTrends in Pharmacological Sciences, 2008
- AT1 Receptors and Control of Blood Pressure: The Kidney and More…Trends in Cardiovascular Medicine, 2007
- Recombinant human keratinocyte growth factor palifermin reduces oral mucositis and improves patient outcomes after stem cell transplantDrugs of Today, 2007
- Protein kinase Cδ-mediated proteasomal degradation of MAP kinase phosphatase-1 contributes to glutamate-induced neuronal cell deathJournal of Cell Science, 2006